Delivery Order SPE2DB25D2203-SPE2DB25FPSGQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,413.38 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 gram formulation) on September 11, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler (4 grams) with a ceiling value of $1,629.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract is scheduled for completion by September 15, 2025, with fulfillment from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,844.50 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 gm). This competitively awarded, firm fixed-price contract has a completion date of June 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $2,982.05 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in 4GM quantity. This non-competitive, firm fixed-price delivery order was awarded on May 15, 2025, with an ultimate completion date of May 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,429.73 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.12 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4gm) with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition in federal procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in a 4 GM formulation, with a ceiling value of $1,779.64. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) with a ceiling value of $4,633.86. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 12, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB25FPSGQDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalant (4 gm) with a ceiling value of $1,651.33. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award reflects AmerisourceBergen's established role as a primary pharmaceutical distributor for federal military and veteran healthcare systems. Spiriva Respimat is a maintenance bronchodilator therapy used for chronic obstructive pulmonary disease management, representing the type of specialized pharmaceutical products the contractor routinely supplies to support military healthcare programs. As a major pharmaceutical vendor with demonstrated capability to fulfill federal medical procurement requirements, AmerisourceBergen continues to leverage its comprehensive IDC to supply critical medications and medical supplies across multiple therapeutic domains to the Defense Health Agency and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/5/25 |